The Readout Loud

Episodes

• 222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment

  Aug 18, 2022

  Not summarized yet

• 221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing

  Aug 11, 2022

  Not summarized yet

• 220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble

  Aug 4, 2022

  Not summarized yet

• 219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data

  Jul 28, 2022

  Not summarized yet

• 218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search

  Jul 21, 2022

  Not summarized yet

• 217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'

  Jul 14, 2022

  Not summarized yet

• 216: VC malaise, FDA confusion, & yet another Alzheimer's debate

  Jul 7, 2022

  Not summarized yet

• 215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines

  Jun 30, 2022

  Not summarized yet

• 214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict

  Jun 23, 2022

  Not summarized yet

• 213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback

  Jun 16, 2022

  Not summarized yet

• 212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

  Jun 9, 2022

  Not summarized yet

• 211: Biotech's catch-22, a $100 genome, & dealing with monkeypox

  Jun 2, 2022

  Not summarized yet

• 210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

  May 26, 2022

  Not summarized yet

• Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison

  May 19, 2022

  Not summarized yet

• Episode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise

  May 12, 2022

  Not summarized yet

• Episode 207: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner

  May 5, 2022

  Not summarized yet

• Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum

  Apr 28, 2022

  Not summarized yet

• Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices

  Apr 21, 2022

  Not summarized yet

• Episode 204: Leana Wen on the pandemic's new normal and whether Twitter is real life

  Apr 14, 2022

  Not summarized yet

• Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success

  Apr 7, 2022

  Not summarized yet